Sangamo Therapeutics Inc. (SGMO)
NASDAQ: SGMO
· Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT
Sangamo Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 38.34M | 25.18M | 41.92M | 39.2M | 27.79M | 54.42M | 45.2M | 56.51M | 66.83M | 78.24M | 100.44M | 94.57M | 117.7M | 120.26M | 178.87M | 176.95M | 169.88M | 122.97M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 35.8M | 75.6M | 76.27M | 127.15M | 177.19M | 219M | 198.02M | 197.54M | 197.68M | 246.46M | 359.77M | 464.11M |
Long-Term Investments | 1.5M | 1.5M | 1.5M | 1.5M | n/a | n/a | n/a | n/a | 39.04M | 35.61M | 29.84M | 36.7M | 47.97M | 82.52M | 88.17M | 95.63M | 49.2M | 42.43M |
Other Long-Term Assets | 15.37M | 14.23M | 13.69M | 14.72M | 13.65M | 17.37M | 18.13M | 16.47M | 18.94M | 11.37M | 17.41M | 12.96M | 11.49M | 11.11M | 16.82M | 10.08M | 9.44M | 8.73M |
Receivables | 372K | 4.61M | 4.6M | 10.5M | 581K | 691K | 4.07M | 1.75M | 3.94M | 8.05M | 4.47M | 5.05M | 6.29M | 7.29M | 6.36M | 8.59M | 7.69M | 7.72M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36.7M | n/a | n/a | -88.17M | n/a | n/a | n/a |
Other Current Assets | 11.18M | 7.81M | 5.17M | 8.43M | 11.71M | 13.53M | 9.26M | 13.71M | 12.57M | 13.65M | n/a | 18.01M | 21.11M | 14.97M | n/a | 15.4M | 16.72M | 12.14M |
Total Current Assets | 49.89M | 37.6M | 51.69M | 58.13M | 40.08M | 68.64M | 94.33M | 147.58M | 159.61M | 227.09M | 300.33M | 336.62M | 343.12M | 340.06M | 398.77M | 447.4M | 554.06M | 606.94M |
Property-Plant & Equipment | 30.79M | 32.84M | 34.76M | 36.91M | 39.29M | 42.95M | 52.87M | 55.65M | 107.49M | 108.57M | 125.53M | 120.94M | 122.2M | 122.5M | 124.7M | 117.04M | 117.89M | 115.55M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51.55M | 88.28M | 80.95M | 86.23M | 91.61M | 93.46M | 95.46M | 97.8M | 96.58M |
Total Long-Term Assets | 47.66M | 48.57M | 49.94M | 53.13M | 52.94M | 60.33M | 70.99M | 72.12M | 165.47M | 213.48M | 262.18M | 257.29M | 274.01M | 314.25M | 323.15M | 325M | 281.3M | 270.15M |
Total Assets | 97.56M | 86.17M | 101.64M | 111.26M | 93.01M | 128.96M | 165.32M | 219.7M | 325.07M | 440.57M | 562.51M | 593.91M | 617.13M | 654.31M | 721.92M | 772.4M | 835.36M | 877.1M |
Account Payables | 10.74M | 18.2M | 15.48M | 19.79M | 17.59M | 15.47M | 15.26M | 15.46M | 14.84M | 19.92M | 22.42M | 17.38M | 13.08M | 11.15M | 9.76M | 7.98M | 10.13M | 11.64M |
Deferred Revenue | 7.56M | 7.56M | 7.56M | 774K | n/a | n/a | n/a | 1.49M | 6.87M | 9.57M | 51.78M | 71.89M | 78.79M | 80.78M | 85.71M | 90.45M | 93.96M | 94.36M |
Short-Term Debt | n/a | n/a | 4.31M | n/a | n/a | n/a | 4.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 13.94M | 14.01M | 14.57M | 10.96M | 5.04M | 7.47M | 7.14M | 14.23M | 18.96M | 15.39M | 11.88M | 14.05M | 14.2M | 14.1M | 7.55M | 14.82M | 15.45M | 13.76M |
Total Current Liabilities | 47.66M | 49.56M | 45.8M | 43.16M | 39.01M | 40.24M | 47.73M | 48.48M | 53.79M | 57.84M | 111.71M | 122.36M | 119.99M | 118.53M | 127.89M | 131.9M | 136.94M | 132.84M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 962K | 933K | 933K | 1.24M | 1.22M | 1.21M | 1.19M | 1.32M | 1.27M | 1.23M | 1.21M | 1.31M | 1.28M | 1.24M | 1.22M | 7.63M | 7.42M | 7.23M |
Total Long-Term Liabilities | 30.3M | 31.7M | 33.06M | 28.97M | 30.32M | 32.02M | 34.7M | 36.29M | 37.64M | 47.12M | 155.84M | 162.4M | 178.86M | 201.26M | 218.69M | 234.48M | 252.96M | 274.84M |
Total Liabilities | 77.96M | 81.26M | 78.86M | 72.13M | 69.32M | 72.26M | 82.43M | 84.78M | 91.43M | 104.96M | 267.55M | 284.76M | 298.85M | 319.79M | 346.58M | 366.38M | 389.91M | 407.68M |
Total Debt | 23.46M | 24.88M | 30.57M | 27.73M | 29.1M | 30.82M | 38.1M | 34.98M | 36.37M | 37.7M | 43.11M | 39.7M | 41.53M | 42.81M | 48.08M | 36.12M | 37.33M | 38.46M |
Common Stock | 2.73M | 2.25M | 2.13M | 2.09M | 2.08M | 2.04M | 1.78M | 1.77M | 1.77M | 1.72M | 1.67M | 1.62M | 1.53M | 1.47M | 1.46M | 1.46M | 1.45M | 1.44M |
Retained Earnings | -1.55B | -1.53B | -1.5B | -1.48B | -1.49B | -1.46B | -1.41B | -1.35B | -1.24B | -1.13B | -1.15B | -1.1B | -1.04B | -1B | -956.27M | -918.77M | -871.08M | -823.91M |
Comprehensive Income | -1.46M | -5.53M | -7.53M | -4.22M | -5.88M | -5.8M | -4.59M | -6.58M | -5.94M | -5.76M | -8.4M | -19M | -13.16M | -6.96M | -3.99M | -623K | 1.99M | 714K |
Shareholders Equity | 19.6M | 4.91M | 22.77M | 39.13M | 23.69M | 56.7M | 82.89M | 134.92M | 233.64M | 335.61M | 294.96M | 309.15M | 318.28M | 334.52M | 375.34M | 406.02M | 445.46M | 470.36M |
Total Investments | 1.5M | 1.5M | 1.5M | 1.5M | n/a | n/a | 35.8M | 75.6M | 115.31M | 162.76M | 207.03M | 255.7M | 245.98M | 280.05M | 285.85M | 342.09M | 408.98M | 506.54M |